4-Nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity
N 4-Methyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4M, 1), N 4, N 4-dimethyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4DM, 2) and N 4-piperidyl-4-nitroacetophenone thiosemicarbazone (H4NO 2Ac4Pip, 3) and their copper(II) complexes [Cu(4NO 2Ac4M) 2] ( 4), [Cu(4NO 2Ac4DM) 2] ( 5) and [Cu(...
Saved in:
Published in | European journal of medicinal chemistry Vol. 43; no. 5; pp. 939 - 948 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
PARIS
Elsevier Masson SAS
01.05.2008
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | N
4-Methyl-4-nitroacetophenone thiosemicarbazone (H4NO
2Ac4M,
1),
N
4,
N
4-dimethyl-4-nitroacetophenone thiosemicarbazone (H4NO
2Ac4DM,
2) and
N
4-piperidyl-4-nitroacetophenone thiosemicarbazone (H4NO
2Ac4Pip,
3) and their copper(II) complexes [Cu(4NO
2Ac4M)
2] (
4), [Cu(4NO
2Ac4DM)
2] (
5) and [Cu(4NO
2Ac4Pip)
2] (
6) were tested for their
in vitro ability to inhibit the growth of
Trypanosoma cruzi epimastigote forms. H4NO
2Ac4DM (
2), [Cu(4NO
2Ac4M)
2] (
4) and [Cu(4NO
2Ac4DM)
2] (
5) proved to be as active as the clinical reference drugs nifurtimox and benznidazol. Taking into consideration the serious side effects and the poor efficacy of the reference drugs, as well as the appearance of resistance during treatment, the studied compounds could constitute a new class of anti-trypanosomal drug candidates.
[Display omitted]
N
4-Methyl- (H4NO
2Ac4M,
1),
N
4,
N
4-dimethyl- (H4NO
2Ac4DM,
2) and
N
4-piperidyl-4-nitroacetophenone thiosemicarbazone (H4NO
2Ac4Pip,
3) and their copper(II) complexes [Cu(4NO
2Ac4M)
2] (
4), [Cu(4NO
2Ac4DM)
2] (
5) and [Cu(4NO
2Ac4Pip)
2] (
6) were tested for their
in vitro ability to inhibit the growth of
Trypanosoma cruzi epimastigote forms. H4NO
2Ac4DM (
2) as well as complexes
4 and
5 proved to be as active as the clinical reference drugs nifurtimox and benznidazol. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2007.06.020 |